TScan Therapeutics, Inc. (TCRX)

NASDAQ: TCRX · Real-Time Price · USD

1.080

+0.045 (4.35%)

At close: Mar 4, 2026, 4:00 PM EST

1.090

+0.010 (0.93%)

After-hours: Mar 4, 2026, 7:01 PM EST

TScan Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	152.41	178.69	133.36	120.03	161.41
Short-Term Investments	-	111.42	58.69	-	-
Cash & Short-Term Investments	152.41	290.11	192.04	120.03	161.41
Cash Growth	-47.47%	51.06%	60.00%	-25.64%	363.93%
Other Current Assets	4.8	2.61	2.19	4.1	4.25
Total Current Assets	157.21	292.72	194.24	124.13	165.65
Net Property, Plant & Equipment	66.45	71.6	71.23	69.2	17.26
Other Long-Term Assets	5.13	6.8	6.68	5.76	5.2
Total Assets	228.79	371.12	272.15	199.09	188.11
Accounts Payable	1.24	4.28	2.37	2.91	1.77
Accrued Expenses	7.67	15.41	10.72	6.84	6.52
Current Portion of Long-Term Debt	-	-	3.35	-	-
Current Portion of Leases	7.17	4.57	3.25	3.68	1.65
Unearned Revenue	2.62	11.7	10.14	3.87	11.41
Total Current Liabilities	18.7	35.96	29.82	17.31	21.34
Long-Term Debt	32.53	32.07	26.7	29.29	-
Long-Term Leases	54.44	60.74	59.14	53.01	4.39
Other Long-Term Liabilities	-	1.38	5.62	0.05	1.59
Total Long-Term Liabilities	86.97	94.19	91.46	82.35	5.99
Total Liabilities	105.67	130.15	121.28	99.66	27.33
Common Stock	0.01	0.01	0.01	0	0
Additional Paid-in Capital	627.98	616.01	398.46	257.81	252.93
Accumulated Other Comprehensive Income	-	0.05	-	-	-
Retained Earnings	-504.86	-375.1	-247.6	-158.38	-92.16
Total Common Shareholders' Equity	123.12	240.97	150.87	99.43	160.78
Shareholders' Equity	123.12	240.97	150.87	99.43	160.78
Total Liabilities & Equity	228.79	371.12	272.15	199.09	188.11
Total Debt	94.14	97.38	92.43	85.98	6.04
Net Cash (Debt)	58.27	192.73	99.61	34.04	155.36
Net Cash Growth	-69.77%	93.48%	192.60%	-78.09%	467.91%
Net Cash Per Share	0.45	1.72	1.52	1.42	13.32
Book Value	123.12	240.97	150.87	99.43	160.78
Book Value Per Share	0.95	2.15	2.30	4.13	13.79
Tangible Book Value	123.12	240.97	150.87	99.43	160.78
Tangible Book Value Per Share	0.95	2.15	2.30	4.13	13.79

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q